In addition, CHRDL2 overexpression in CRC cell lines increased their resistance to chemotherapy by activating DNA repair pathways accompanied by a general enhancement of CSC characteristics due to reduced BMP and elevated WNT signalling [78]. This evidence concerns the gene CHRDL2 and colorectal carcinoma.